A Noninvasive Acupoint Patch as an Adjunct to Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting: A Multicenter Randomized Crossover Trial
This multicenter randomized crossover trial demonstrates that adding the Novel Jiangni Zhitu Patch (N-JZP) to standard dual antiemetic therapy significantly reduces the incidence of moderate-to-severe chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy, with minimal local skin toxicity.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Chemotherapy is a powerful weapon against cancer, but it often brings a heavy cost: severe nausea and vomiting. For many patients, this side effect is not just a temporary discomfort; it can disrupt daily life, prevent proper nutrition, and make people afraid to continue their life-saving treatment. Doctors have long relied on strong medicines to prevent these symptoms, yet even with the best standard drug regimens, a significant number of patients still suffer. This leaves a gap in care where patients need something more, something that can be added to their current treatment without adding more pills or heavy side effects. In the realm of supportive care, researchers are increasingly looking at non-invasive methods that work with the body's natural systems rather than overwhelming it with new chemicals. One such approach involves stimulating specific points on the skin, a practice rooted in traditional medicine, to calm the digestive system and reduce the urge to vomit.
A team of researchers across five hospitals in northern China set out to test whether a simple, non-invasive patch could fill this gap. They focused on patients receiving a specific type of chemotherapy known to cause moderate nausea. The study involved 96 adults who were scheduled to undergo two consecutive rounds of treatment. The researchers designed a clever experiment where each patient served as their own control. In the first round of treatment, half the patients received a standard anti-nausea drug regimen plus a real herbal patch, while the other half received the same drugs plus a fake patch that looked and smelled exactly the same but contained no active ingredients. In the second round, the groups switched: those who had the real patch got the fake one, and vice versa. This crossover design allowed the scientists to compare the effects of the patch directly within the same individuals, minimizing the influence of other factors like age or the severity of their cancer.
The patch itself was a gel-based application containing a blend of three traditional herbal ingredients: processed pinellia, Aucklandia root, and dried ginger. These were applied to three specific spots on the body: two points on the inner wrists and one on the lower abdomen. The researchers applied the patch once a day for six hours, starting on the first day of chemotherapy and continuing for five days. The goal was to see if adding this patch to the standard drug therapy would lower the number of patients who experienced moderate to severe nausea or vomiting. The results were clear. When patients wore the real herbal patch, the rate of moderate to severe nausea and vomiting dropped significantly compared to when they wore the fake patch. Specifically, about 26 percent of the treatment cycles with the real patch resulted in these severe symptoms, whereas the rate was nearly 43 percent when the fake patch was used. This means that for every six patients treated with the patch, one person who would have otherwise suffered severe symptoms was spared.
The study also looked closely at safety and other factors. The patch was well-tolerated, with very few people experiencing skin irritation, and the rate of skin reactions was identical between the real and fake groups. Furthermore, the use of extra "rescue" medicines to stop vomiting did not differ significantly between the two groups, suggesting the patch itself was doing the work. The researchers found that the benefit held true even when they analyzed only the patients who completed both rounds of the study without dropping out. While the study did not measure changes in overall quality of life scores or pain levels in a way that showed a statistical difference, the reduction in severe vomiting is a tangible and meaningful improvement for patients undergoing difficult treatment. The authors note that this approach offers a low-burden option that does not require swallowing more pills or undergoing complex procedures.
This research suggests that adding a simple, non-invasive herbal patch to standard chemotherapy care can provide real relief for patients struggling with nausea. It does not replace the essential anti-nausea drugs that doctors prescribe, but it acts as a helpful partner, reducing the severity of symptoms for many. The findings point toward a future where supportive care might include these gentle, external tools alongside traditional medicine, offering a safer and more comfortable path for patients navigating the challenges of cancer treatment. While the study was limited to patients receiving a specific level of chemotherapy and was conducted in a single region, the results provide a strong foundation for further investigation into how such simple interventions can improve the daily lives of those undergoing cancer therapy.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.